NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Cornovus Pharmaceuticals Inc.

Cornovus Pharmaceuticals Inc.

Private
Farmington, ConnecticutHealthcare & Life Scienceshttps://cornovus.com

Last Round

Seed Round

Jan 26, 2024

Total Funding Raised

$2.45M

Company Overview

Cornovus Pharmaceuticals Inc. is a drug discovery company that develops cardioprotective agents for the treatment of late-stage heart failure.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biotechnologydrug discoverypreclinical researchcardioprotective agentsheart failure treatmentsmall-molecule drugP2X4 receptor agonistbiotech startupIND-enabling studiestherapeutic developmentdrug pipelinebiopharmacardiovascular researchacademic collaborationgrant-funded research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cornovus Pharmaceuticals Inc. Comparables

Compare Cornovus Pharmaceuticals Inc. with similar companies based on industry and business-model similarity.

Cornovus Pharmaceuticals Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Saillant Therapeutics
80%
Serca Pharmaceuticals
78%
Cardurion Pharmaceuticals
78%

Cornovus Pharmaceuticals Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundJan 26, 2024
GrantSep 30, 2017
SeedSep 5, 2016
GrantSep 1, 2015

Cornovus Pharmaceuticals Inc. Investors

Notable investors and investment history

Cornovus Pharmaceuticals Inc. investors
InvestorRounds
Connecticut InnovationsSeed Round, Seed
NIH RADxGrant, Seed, Seed Round
University of Connecticut Technology Incubation ProgramSeed, Seed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 26, 2024

    $500K Seed Round raised.

Cornovus Pharmaceuticals Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Cornovus Pharmaceuticals Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Cornovus Pharmaceuticals Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersFarmington, Connecticut
Year Founded2011
Last FundingJan 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.